Insights from clinical research completed during the west Africa Ebola virus disease epidemic.

Lancet Infect Dis

Epidemic Diseases Research Group Oxford (ERGO), Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK. Electronic address:

Published: September 2017

AI Article Synopsis

  • The West Africa Ebola virus disease (EVD) epidemic was unprecedented in its scale, prompting a significant clinical research response.
  • This review highlights key findings from studies related to risk factors, clinical symptoms, and treatments during the outbreak.
  • It also identifies remaining knowledge gaps and suggests focus areas for future research to improve clinical care in similar health crises.

Article Abstract

The west Africa Ebola virus disease (EVD) epidemic was extraordinary in scale. Now that the epidemic has ended, it is a relevant time to examine published studies with direct relevance to clinical care and, more broadly, to examine the implications of the clinical research response mounted. Clinically relevant research includes literature detailing risk factors for and clinical manifestations of EVD, laboratory and other investigation findings in patients, experimental vaccine and therapeutic clinical trials, and analyses of survivor syndrome. In this Review, we discuss new insights from patient-oriented research completed during the west Africa epidemic, identify ongoing knowledge gaps, and suggest priorities for future research.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856335PMC
http://dx.doi.org/10.1016/S1473-3099(17)30234-7DOI Listing

Publication Analysis

Top Keywords

west africa
12
completed west
8
africa ebola
8
ebola virus
8
virus disease
8
insights clinical
4
clinical completed
4
epidemic
4
disease epidemic
4
epidemic west
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!